Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytogen regains rights to ex vivo prostate cancer immunotherapy

Jan. 7, 2003

Results reported for NBI-3001 in glioblastoma

Jan. 7, 2003

Phase I interim safety data reported for Reolysin in malignant glioma

Jan. 7, 2003

Azido-based photosensitizers covered by Mallinckrodt patent

Jan. 3, 2003

Potential antileukemia agents selected from series of arsonic acids

Jan. 3, 2003

Inhibition of tight junction function as a novel approach to breast cancer

Jan. 3, 2003

SuperGen submits first module of rolling NDA for Orathecin

Jan. 3, 2003

Joint development agreement signed by Beaufour Ipsen and Roche for new anticancer drugs

Jan. 3, 2003

Oxigene begins phase II trial of CA4P in thyroid cancer

Jan. 3, 2003

Discovery of Src kinase inhibitors reported by AstraZeneca

Jan. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...